Mesirow Institutional Investment Management Inc. Purchases 1,200 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Mesirow Institutional Investment Management Inc. increased its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 5.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,980 shares of the biotechnology company’s stock after acquiring an additional 1,200 shares during the quarter. Mesirow […]

Related Keywords

Kentucky ,United States ,Jean Jacques Bienaime ,V Bryan Lawlis ,Johnc Klock ,Securities Exchange Commission ,Victory Capital Management Inc ,Biomarin Pharmaceutical Inc ,Industrial Alliance Investment Management Inc ,Nasdaq ,Penn Capital Management Company ,Exchange Commission ,Mesirow Institutional Investment Management Inc ,Asset Management One Co ,Mesirow Institutional Investment Management ,Biomarin Pharmaceutical ,Get Rating ,Institutional Investment Management ,Retirement System ,Capital Management Company ,Capital Management ,Management One ,Industrial Alliance Investment Management ,Alliance Investment Management ,Jacques Bienaime ,Directorv Bryan Lawlis ,Avian Securities ,Marin Pharmaceutical Trading Down ,Marin Pharmaceutical ,Biomarin Pharmaceutical Daily ,Nasdaq Bmrn ,Bmrn ,Medical ,09061g10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,